Surface Oncology to Present New Preclinical SRF114 Data at the American Association for Cancer Research Annual Meeting 2023
Roughly 67% of Surface Oncology's investor base is looking to short. The analysis of current outlook of investing in Surface Oncology suggests that many traders are alarmed regarding Surface Oncology's prospects. The current market sentiment, together with Surface Oncology's historical and current headlines, can help investors time the market. In addition, many technical investors use Surface Oncology stock news signals to limit their universe of possible portfolio assets.
Surface |
CAMBRIDGE, Mass., March 16, 2023 -- Surface Oncology , a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today
Read at benzinga.com
 |
Surface Oncology Fundamental Analysis
We analyze Surface Oncology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Surface Oncology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Surface Oncology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
Surface Oncology is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Surface Oncology Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Surface Oncology stock to make a market-neutral strategy. Peer analysis of Surface Oncology could also be used in its relative valuation, which is a method of valuing Surface Oncology by comparing valuation metrics with similar companies.
Peers
Surface Oncology Related Equities
| IOVA | Iovance Biotherapeutics | 4.57 | ||||
| RPTX | Repare Therapeutics | 2.21 | ||||
| EVGN | Evogene | 1.83 | ||||
| PSNL | Personalis | 2.34 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Consideration for investing in Surface Stock
If you are still planning to invest in Surface Oncology check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Surface Oncology's history and understand the potential risks before investing.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Stocks Directory Find actively traded stocks across global markets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |